Emerald Advisers, LLC Applied Genetic Technologies Corp Transaction History

Emerald Advisers, LLC

  • $2.41 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 05, 2018
SELL
$3.4 - $4.15 $36,975 - $45,131
-10,875 Closed
0 $0
Q3 2017

Oct 30, 2017
BUY
$3.55 - $5.25 $38,606 - $57,093
10,875
10,875 $43,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email